メニュー  → 生薬成分の代謝  → 
Gentiopicroside
Gentiopicroside

化合物名 Gentiopicroside 
動物種 ヒト腸内細菌フローラ、ヒト腸内細菌株 Veillonella parvula他 
代謝パラメータ  
代謝物 Gentiopicroside
(6R)-6-hydroxy-5-vinyl-5,6-dihydropyrano[3,4-c]pyran-1(3H)-one
(E)-2-(3-(hydroxymethylene)-2-oxo-3,6-dihydro-2H-pyran-4-yl)but-3-enal
3-methyl-8-oxo-3,4,6,8-tetrahydropyrano[3,4-c]pyran-4-carbaldehyde
(5S,6S)-5-(hydroxymethyl)-6-methyl-5,6-dihydropyrano[3,4-c]pyran-1(3H)-one
3-methyl-8-oxo-3,5,6,8-tetrahydropyrano[3,4-c]pyran-4-carbaldehyde
2-oxo-4-(1-oxobut-3-en-2-yl)-5,6-dihydro-2H-pyran-3-carbaldehyde
8-hydroxy-1-oxo-3,4,7,8-tetrahydro-1H-isochromene-5-carbaldehyde
1-oxoisochroman-5-carbaldehyde
5-(hydroxymethyl)isochroman-1-one
5-(hydroxymethyl)-1H-isochromen-1-one
関連生薬 ゲンチアナ , センブリ 
参考文献 1) El-Sedawy A. I., Hattori M., Kobashi K., and Namba T.: Metabolism of gentiopicroside (gentiopicrin) by human intestinal bacteria. Chem. Pharm. Bull. 37, 2435-2437 (1989). 
論文備考 ※Each bacterium was cultured in the presence of gentiopicroside (1) for 24 h at 37 °C.
The products were extracted with EtOAc and analyzed by TLC-densitometry. The peaks corresponding to metabolites are represented by G—G5; other peaks originate from the bacterial cells and culture broth. The Rf values of these metabolites on TLC with CHCl3-MeOH (15:1) were as follows: G1, 0.92; G2, 0.85; G3, 0.59; G4 and G5, 0.46—0.50.

※Screening of intestinal bacterial strains for ability to metabolize gentiopicroside (1)
Each precultured bacterial strain (0.2 ml) was added to GAM broth (10 ml) and cultured for 24 h at 37 °C under anaerobic conditions. Gentiopicroside (1) was added to each culture, and the mixturewas incubated for 22 h under the same conditions and then extracted with EtOAc (10 ml). After evaporation of the EtOAc, CHCl3-MeOH (1:1, 0.5 ml) was added to the residue and an aliquot (50 μl) of the solution was applied to a silica gel TLC plate, which was developed with CHCl3-MeOH (15:1). The metabolites separated on the plate were quantitatively analyzed with a TLC scanner at 230 nm relative to a reference wavelength of 550 nm. [El-Sedawy et al., Chem. Pharm. Bull. 37, 2435-2437 (1989)]

※Isolation of metabolites
A precultured bacterial suspension (100 ml) of Veillonella parvula ss parvula ATCC 10790 was added to GAM broth (900 ml) and incubated for 24 h at 37 °C in an anaerobic jar, in which air had been replaced with O2-free CO2 in the presence of steel wool. [El-Sedawy et al., Chem. Pharm. Bull. 37, 2435-2437 (1989)]

※Gentiopicroside (1, 1 g in 5 ml of 0.1 M phosphate buffer, pH 7.4) was then added, and the mixture was anaerobically incubated for 22 h at 37 °C and extracted 3 times with EtOAc (1000 ml each). The combined solutions were concentrated in vacuo to give an oily residue. The residue was applied to a column of silica gel, which was washed with hexane and eluted successively with benzene, benzene-CHCl3 (3:1) and benzene-CHCl3 (2:1) to afford five metabolites, G1 (3 mg), G2 (3 mg), G3 (14 mg) and G4 + G5 (12 mg). Repeated preparative TLC of a mixture of G4 and G5 gave two pure compounds. [El-Sedawy et al., Chem. Pharm. Bull. 37, 2435-2437 (1989)] 
 

TOPICS

遺伝子解析情報

活性試験情報

生薬成分の代謝情報

伝統医薬データベース


富山大学和漢医薬学総合研究所
研究開発部門
資源開発分野
資源科学領域
〒930-0194
富山県富山市杉谷 2630
TEL: 076-434-7601
FAX: 076-434-5064